Skip to main content

Freestone Capital Holdings, LLC

Position in NVO — Novo Nordisk A S

CIK 1470876 Seattle, WA

Position in NVO

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$1,788,353
+$882,429 QoQ
Shares Held
37,304
+51.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#402
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Freestone Capital Holdings, LLC holds $84,369,882 across 11 Drug Manufacturers - General names. NVO ranks #6 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVO
Novo Nordisk A S
This page
37,304 $1,788,353

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,788,353 37,304
2026-03-31 $905,924 24,651
2025-12-31 $1,268,133 24,924
2025-09-30 $3,166,092 57,057
2025-06-30 $1,663,658 24,104
2025-03-31 $1,544,970 22,249
2024-12-31 $2,814,574 32,720
2024-09-30 $3,955,624 33,221
2024-06-30 $4,889,273 34,253
2024-03-31 $4,410,026 34,346
2023-12-31 $3,617,232 34,966
2023-09-30 $3,195,449 35,138
2023-06-30 $2,934,948 18,136
2023-03-31 $3,137,604 19,716
2022-12-31 $2,772,575 20,486
2022-09-30 $3,127,983 31,396
2022-06-30 $4,736,220 42,504
2022-03-31 $5,637,453 50,765
2021-12-31 $5,857,712 52,301
2021-09-30 $5,283,622 55,032
2021-06-30 $4,721,360 56,361
2021-03-31 $3,803,364 56,413
2020-12-31 $4,238,218 60,676
2020-09-30 $3,323,058 47,862
2020-06-30 $3,325,663 50,789
2020-03-31 $3,417,855 56,775